Budget Reconciliation Provisions Relating to PBM’s
Posted on Substack (Link) The recent spending bill includes interesting provisions that affect all of healthcare. The passage of the bill is beyond the scope of this article. However, if…
340B Primer Part 2: Diversion.
Link to post on Substack (Link) Diversion. Diversion is a significant concern for manufacturers. Diversion is when a CE or a contracted pharmacy knowingly and intentionally resells or transfers a…
340B Primer
Dec 04, 2024 340B Program: Nonprofit hospitals and federally funded clinics receive outpatient drug discounts through this program, with drug manufacturers required to offer drugs at or below-specified discounts. Background…
Physical Takings and the Inflation Reduction Act: Evaluating whether the IRA’s Drug Negotiation Provisions constitute a physical taking under the Fifth Amendment
Introduction “For years, Big Pharma won. Big Pharma blocked us. But not this time…This time, we finally beat Big Pharma.” President Joe Biden The Inflation Reduction Act (IRA) is the…
Drug Pricing Contracts in the U.S. Healthcare System: Models and Examples
Introduction The U.S. healthcare system is highly complex. A network of entities including manufacturers, pharmacy benefit managers (PBMs), insurers, pharmacies, and patients exchange products, money, services, and contracts. These contracts…